Photo from wikipedia
Intravenous immunoglobulin (IVIg) is recommended in Guillain–Barré syndrome (GBS), but its efficacy may vary in different subtypes. We report the outcomes of patients with GBS following IVIg treatment compared to… Click to show full abstract
Intravenous immunoglobulin (IVIg) is recommended in Guillain–Barré syndrome (GBS), but its efficacy may vary in different subtypes. We report the outcomes of patients with GBS following IVIg treatment compared to the natural course (NC). We also compare the effect of IVIg treatment in different subtypes of GBS.
Keywords:
barr syndrome;
natural course;
compared natural;
guillain barr;
intravenous immunoglobulin
Journal Title: European Journal of Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!